Buckhalter Matthew 4
4 · Aveanna Healthcare Holdings, Inc. · Filed Feb 19, 2026
Research Summary
AI-generated summary of this filing
Aveanna CFO Matthew Buckhalter Sells Shares
What Happened
Matthew Buckhalter, Chief Financial Officer of Aveanna Healthcare (AVAH), reported three sales between Feb 17–19, 2026. The transactions total 36,030 shares disposed for aggregate proceeds of approximately $266,097: 9,351 shares at $7.65 ($71,489) on Feb 17; 13,167 shares at $7.38 ($97,211) on Feb 18; and 13,512 shares at $7.21 ($97,397) on Feb 19. These are sales (not purchases) and per the filing appear to include automatic sales to satisfy tax withholding on vested equity.
Key Details
- Transaction dates and amounts:
- 2026-02-17: 9,351 shares @ $7.65 = $71,489
- 2026-02-18: 13,167 shares @ $7.38 = $97,211
- 2026-02-19: 13,512 shares @ $7.21 = $97,397
- Total: 36,030 shares sold for ~$266,097.
- Shares owned after the transactions: not specified in the provided filing.
- Footnotes of note:
- F1: Some shares were automatically sold to satisfy the reporting person's tax obligation upon vesting of equity awards.
- F2–F4: Prices shown may be weighted averages from aggregate sales handled by the company’s stock plan administrator; price ranges for those aggregated lines are provided in the filing and the reporting person will supply per-price details to the SEC or company upon request.
- Filing timeliness: Form 4 was filed on Feb 19, 2026 covering transactions from Feb 17–19; no late filing indication in the provided information.
Context
These sales appear routine and include tax-withholding dispositions tied to vested awards rather than open-market purchases that might signal new insider conviction. For retail investors, purchases generally carry more informational weight than routine sales; here the filing documents tax-related and plan-administered sales rather than a directional trade by the insider.
Insider Transaction Report
- Sale
Common Stock, par value $0.01 per share
[F1][F2]2026-02-17$7.65/sh−9,351$71,489→ 555,922 total - Sale
Common Stock, par value $0.01 per share
[F1][F3]2026-02-18$7.38/sh−13,167$97,211→ 542,755 total - Sale
Common Stock, par value $0.01 per share
[F1][F4]2026-02-19$7.21/sh−13,512$97,397→ 529,243 total
Footnotes (4)
- [F1]Represents shares of common stock automatically sold to satisfy the reporting person's tax obligation in respect of the shares issued upon vesting of equity awards, as previously reported.
- [F2]The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $7.47 to $7.97. This transaction was part of aggregate sales by our stock plan administrator. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $7.175 to $7.53. This transaction was part of aggregate sales by our stock plan administrator. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F4]The price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $7.06 to $7.29. This transaction was part of aggregate sales by our stock plan administrator. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.